Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation

Premature ovarian insufficiency (POI) is defined as a cessation of ovarian function before the age of 40 years. It is associated with hypoestrogenism and loss of residual follicles, both of which lead to menstrual abnormalities, pregnancy failures, and decreased health-related quality of life. The p...

Full description

Bibliographic Details
Main Authors: Ewa Rudnicka, Jagoda Kruszewska, Klaudia Klicka, Joanna Kowalczyk, Monika Grymowicz, Jolanta Skórska, Wojciech Pięta, Roman Smolarczyk
Format: Article
Language:English
Published: Termedia Publishing House 2018-09-01
Series:Menopause Review
Subjects:
Online Access:https://www.termedia.pl/Premature-ovarian-insufficiency-aetiopathology-epidemiology-and-diagnostic-evaluation,4,33841,1,1.html
id doaj-106a30bf79bb4d28bc99ee27c3adc189
record_format Article
spelling doaj-106a30bf79bb4d28bc99ee27c3adc1892020-11-25T01:22:56ZengTermedia Publishing HouseMenopause Review1643-88762299-00382018-09-0117310510810.5114/pm.2018.7855033841Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluationEwa RudnickaJagoda KruszewskaKlaudia KlickaJoanna KowalczykMonika GrymowiczJolanta SkórskaWojciech PiętaRoman SmolarczykPremature ovarian insufficiency (POI) is defined as a cessation of ovarian function before the age of 40 years. It is associated with hypoestrogenism and loss of residual follicles, both of which lead to menstrual abnormalities, pregnancy failures, and decreased health-related quality of life. The prevalence of POI is estimated at 1% in the general population. Current European Society of Human Reproduction and Embryology (ESHRE) diagnostic criteria include: amenorrhoea or oligomenorrhoea for at least four months and increased follicle-stimulating hormone (FSH) levels > 25 IU/l measured twice (with a four-week interval). The aetiopathogenesis of the disease in most cases remains unexplained. Nevertheless, in some patients with POI, genetic abnormalities, metabolic disorders, autoimmunity, iatrogenic procedures, infections, or environmental factors have been established as underlying causes of the syndrome.https://www.termedia.pl/Premature-ovarian-insufficiency-aetiopathology-epidemiology-and-diagnostic-evaluation,4,33841,1,1.htmlpremature ovarian insufficiency Turner syndrome autoimmunity
collection DOAJ
language English
format Article
sources DOAJ
author Ewa Rudnicka
Jagoda Kruszewska
Klaudia Klicka
Joanna Kowalczyk
Monika Grymowicz
Jolanta Skórska
Wojciech Pięta
Roman Smolarczyk
spellingShingle Ewa Rudnicka
Jagoda Kruszewska
Klaudia Klicka
Joanna Kowalczyk
Monika Grymowicz
Jolanta Skórska
Wojciech Pięta
Roman Smolarczyk
Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation
Menopause Review
premature ovarian insufficiency
Turner syndrome
autoimmunity
author_facet Ewa Rudnicka
Jagoda Kruszewska
Klaudia Klicka
Joanna Kowalczyk
Monika Grymowicz
Jolanta Skórska
Wojciech Pięta
Roman Smolarczyk
author_sort Ewa Rudnicka
title Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation
title_short Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation
title_full Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation
title_fullStr Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation
title_full_unstemmed Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation
title_sort premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation
publisher Termedia Publishing House
series Menopause Review
issn 1643-8876
2299-0038
publishDate 2018-09-01
description Premature ovarian insufficiency (POI) is defined as a cessation of ovarian function before the age of 40 years. It is associated with hypoestrogenism and loss of residual follicles, both of which lead to menstrual abnormalities, pregnancy failures, and decreased health-related quality of life. The prevalence of POI is estimated at 1% in the general population. Current European Society of Human Reproduction and Embryology (ESHRE) diagnostic criteria include: amenorrhoea or oligomenorrhoea for at least four months and increased follicle-stimulating hormone (FSH) levels > 25 IU/l measured twice (with a four-week interval). The aetiopathogenesis of the disease in most cases remains unexplained. Nevertheless, in some patients with POI, genetic abnormalities, metabolic disorders, autoimmunity, iatrogenic procedures, infections, or environmental factors have been established as underlying causes of the syndrome.
topic premature ovarian insufficiency
Turner syndrome
autoimmunity
url https://www.termedia.pl/Premature-ovarian-insufficiency-aetiopathology-epidemiology-and-diagnostic-evaluation,4,33841,1,1.html
work_keys_str_mv AT ewarudnicka prematureovarianinsufficiencyaetiopathologyepidemiologyanddiagnosticevaluation
AT jagodakruszewska prematureovarianinsufficiencyaetiopathologyepidemiologyanddiagnosticevaluation
AT klaudiaklicka prematureovarianinsufficiencyaetiopathologyepidemiologyanddiagnosticevaluation
AT joannakowalczyk prematureovarianinsufficiencyaetiopathologyepidemiologyanddiagnosticevaluation
AT monikagrymowicz prematureovarianinsufficiencyaetiopathologyepidemiologyanddiagnosticevaluation
AT jolantaskorska prematureovarianinsufficiencyaetiopathologyepidemiologyanddiagnosticevaluation
AT wojciechpieta prematureovarianinsufficiencyaetiopathologyepidemiologyanddiagnosticevaluation
AT romansmolarczyk prematureovarianinsufficiencyaetiopathologyepidemiologyanddiagnosticevaluation
_version_ 1725124573718904832